182 related articles for article (PubMed ID: 22638073)
1. Biasing the prostaglandin F2α receptor responses toward EGFR-dependent transactivation of MAPK.
Goupil E; Wisehart V; Khoury E; Zimmerman B; Jaffal S; Hébert TE; Laporte SA
Mol Endocrinol; 2012 Jul; 26(7):1189-202. PubMed ID: 22638073
[TBL] [Abstract][Full Text] [Related]
2. A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas.
Sales KJ; List T; Boddy SC; Williams AR; Anderson RA; Naor Z; Jabbour HN
Cancer Res; 2005 Sep; 65(17):7707-16. PubMed ID: 16140938
[TBL] [Abstract][Full Text] [Related]
3. Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.
Kim J; Ahn S; Rajagopal K; Lefkowitz RJ
J Biol Chem; 2009 May; 284(18):11953-62. PubMed ID: 19254952
[TBL] [Abstract][Full Text] [Related]
4. A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2alpha synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1/2 signaling pathway.
Jabbour HN; Sales KJ; Boddy SC; Anderson RA; Williams AR
Endocrinology; 2005 Nov; 146(11):4657-64. PubMed ID: 16081631
[TBL] [Abstract][Full Text] [Related]
5. Expression, localization, and signaling of prostaglandin F2 alpha receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways.
Sales KJ; Milne SA; Williams AR; Anderson RA; Jabbour HN
J Clin Endocrinol Metab; 2004 Feb; 89(2):986-93. PubMed ID: 14764825
[TBL] [Abstract][Full Text] [Related]
6. AL-3138 antagonizes FP prostanoid receptor-mediated inositol phosphates generation: comparison with some purported FP antagonists.
Sharif NA; Crider JY; Davis TL
J Pharm Pharmacol; 2000 Dec; 52(12):1529-39. PubMed ID: 11197083
[TBL] [Abstract][Full Text] [Related]
7. Activated human hydroxy-carboxylic acid receptor-3 signals to MAP kinase cascades via the PLC-dependent PKC and MMP-mediated EGFR pathways.
Zhou Q; Li G; Deng XY; He XB; Chen LJ; Wu C; Shi Y; Wu KP; Mei LJ; Lu JX; Zhou NM
Br J Pharmacol; 2012 Jul; 166(6):1756-73. PubMed ID: 22289163
[TBL] [Abstract][Full Text] [Related]
8. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
[TBL] [Abstract][Full Text] [Related]
9. Effects of prostaglandin F2alpha, latanoprost and carbachol on phosphoinositide turnover, MAP kinases, myosin light chain phosphorylation and contraction and functional existence and expression of FP receptors in bovine iris sphincter.
Ansari HR; Kaddour-Djebbar I; Abdel-Latif AA
Exp Eye Res; 2004 Feb; 78(2):285-96. PubMed ID: 14729360
[TBL] [Abstract][Full Text] [Related]
10. Role for engagement of β-arrestin2 by the transactivated EGFR in agonist-specific regulation of δ receptor activation of ERK1/2.
Zhang LS; Wang YJ; Ju YY; Zan GY; Xu C; Hong MH; Wang YH; Chi ZQ; Liu JG
Br J Pharmacol; 2015 Oct; 172(20):4847-63. PubMed ID: 26211551
[TBL] [Abstract][Full Text] [Related]
11. Protection of 6-OHDA neurotoxicity by PGF
Sano A; Maehara T; Fujimori K
Toxicology; 2021 Feb; 450():152686. PubMed ID: 33486071
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element.
Sales KJ; Grant V; Jabbour HN
Mol Cell Endocrinol; 2008 Mar; 285(1-2):51-61. PubMed ID: 18316157
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 selectively antagonizes prostaglandin F2alpha-stimulated T-cell factor/beta-catenin signaling pathway by the FPB prostanoid receptor.
Fujino H; Vielhauer GA; Regan JW
J Biol Chem; 2004 Oct; 279(42):43386-91. PubMed ID: 15280380
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type I and prostaglandin F2α receptors cooperatively modulate signaling in vascular smooth muscle cells.
Goupil E; Fillion D; Clément S; Luo X; Devost D; Sleno R; Pétrin D; Saragovi HU; Thorin É; Laporte SA; Hébert TE
J Biol Chem; 2015 Jan; 290(5):3137-48. PubMed ID: 25512374
[TBL] [Abstract][Full Text] [Related]
15. F-prostanoid receptor regulation of fibroblast growth factor 2 signaling in endometrial adenocarcinoma cells.
Sales KJ; Boddy SC; Williams AR; Anderson RA; Jabbour HN
Endocrinology; 2007 Aug; 148(8):3635-44. PubMed ID: 17478553
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of inhibition of 3T3-L1 preadipocyte differentiation by prostaglandin F2alpha.
Miller CW; Casimir DA; Ntambi JM
Endocrinology; 1996 Dec; 137(12):5641-50. PubMed ID: 8940395
[TBL] [Abstract][Full Text] [Related]
17. Augmented Angiogenic Factors Expression via FP Signaling Pathways in Peritoneal Endometriosis.
Rakhila H; Al-Akoum M; Doillon C; Lacroix-Pépin N; Leboeuf M; Lemyre M; Akoum A; Pouliot M
J Clin Endocrinol Metab; 2016 Dec; 101(12):4752-4763. PubMed ID: 27726474
[TBL] [Abstract][Full Text] [Related]
18. beta-Arrestin mediates beta1-adrenergic receptor-epidermal growth factor receptor interaction and downstream signaling.
Tilley DG; Kim IM; Patel PA; Violin JD; Rockman HA
J Biol Chem; 2009 Jul; 284(30):20375-86. PubMed ID: 19509284
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of the conserved Asp2.50 and ERY motif reveals signaling bias of the urotensin II receptor.
Proulx CD; Holleran BJ; Boucard AA; Escher E; Guillemette G; Leduc R
Mol Pharmacol; 2008 Sep; 74(3):552-61. PubMed ID: 18509066
[TBL] [Abstract][Full Text] [Related]
20. Cross talk between PKC and CREB in the induction of COX-2 by PGF2α in human amnion fibroblasts.
Guo CM; Kasaraneni N; Sun K; Myatt L
Endocrinology; 2012 Oct; 153(10):4938-45. PubMed ID: 22919060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
